Different Anticoagulant Response to Activated Protein C (APC test) and to Agkistrodon Contortix Venom (ACV test) in a Family with FV-R506Q Substitution

Clinical and Applied Thrombosis/Hemostasis

Volumn 3, Issue 3, 1997, Pages 168-173

  Gemmati, Donato ^a   Serino, Maria L ^a   Mari, Rosella ^a   Verzola, Isabella ^a   Moratelli, Stefano ^a   Ballerini, Giorgio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

ACV test; APC resistance; APC test; Diagnosis; Factor V Leiden; Inherited thrombophilia

Indexed keywords

EID: 85174221066     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/107602969700300304     Document Type: Article

References (44)

1. Esmon CT Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 1993;70:29-35.
2. Dahlbäck B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 1995 ;77:1-43.
3. Walker FJ Regulation of activated protein C by protein S: The role of phospholipids in factor Va inactivation. J Biol Chem 198 1;256: 11128-31.
4. Shen L., Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa: J Biol Cliem 1994;269:18735-8.
5. Varadi K. Rosing J. Tans G., Pabinger I., Keil B., Schwarz HP Factor V enhances the cofactor function of protein S in the APCmediated inactivation of factor VIII: Influence of the factor V R506Q mutation. Thromb Haemost 1996 ;76:208-14.
6. Gladson CL, Scharrer I., Hack V., Beck KH, Griffin JH The frequency of type heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988;59:18-22.
7. Ben-Tal O., Zivelin A., Seligsohn U. The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost 1989;61:50-4.
8. Tabernero MD, Thomas JF, Alberca I., Orfao A., Borrasca AL, Vicente V. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol 1991 ;36: 249-54.
9. Dahlbäck B., Carlsson M., Svensson PJ Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90: 1004-8.
10. Bertina RM, Koelemztn Bpc, Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;364:64-7.
11. Svensson PJ Dahtback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-22.
12. Rees DC, Cox M., Clegg JB World distribution of factor V Leiden. Lancet 1995;346:1133-4.
13. Takamiya O., Ishida F., Kodaira H., Kitano K. APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haetnost 1995;74:996.
14. Dahlbäck B., Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc AM Acad Sci USA 1994;91:1396-400.
15. Zöller B., Dahlibäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994 ;343:1536-8.
16. Koster T., Rosendaal FR, de Ronde H., Briât E., Vandenbroucke JP, Bertina EM Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993 ;342:1503-6.
17. Pabinger I., Brücker S., Kyrle PA, Schneider B., Korninger HC Niessner H., Lechner K. Hereditary deficiency of antithrombin III, protein C and protein S: Prevalence in patients with a history of venous thrombosis and criteria for rational patients screening. Blood Coag Fibrinol 1992;3:547-53.
18. Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Haemost 1990 16:299-309.
19. Greengard JS, Eichinger S., Griffin JH, Bauer KA Brief report: Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg→Gln mutation in the gene for factor V. N Engl J Med 1994;331:1559-62.
20. Kraus M. Noah M., Fickenscher K. The PCAT- A simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res 1995;79:217-22.
21. Denson Kwe, Haddon ME, Reed SV, Davidson S., Littlewood TJ A more discriminant test for APC resistance and a possible screening test to include protein C and protein S. Thromb Res 1996:81: 151-6.
22. Robert A., Escwège V., Hameg H., Drouet L., Aillaud MF Anticoagulant response to Agkistrodon Contortix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway. Thromb Haemost 1996;75:562-6.
23. Preda L., Simioni P., Legnani C., Palareti G., Poggio M., Rossi E., Girolami A. A new global test for the evaluation of the protein C-protein S system. Blood Coag Fibrinol 1996;7:465-9.
24. Jorquera JI, Montoro JM, Ferriartdez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994;344: 1162-3.
25. Trossaërt M., Conard J., Horellou MH, Samama MM, Ireland H., Buyston TA, Lane DA Modified APC resistance assay for patients on oral anticoagulants. Lancet 1994;344:1,709.
26. Beauhamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994:88:219-22.
27. Faioni EM, Franchi F., Asti D., Sacchi E., Bernardi F., Mannucci PM Resistance to activated protein C in nine thrombophilic families: Interference in a protein S functional assay. Thromb Haemost 1993;70:1067-71.
28. Cooper PC, Hampton KK, Makris M., Abuzenadah A., Paul B., Preston FE Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency. Br J Haematol 1994;88:201-3.
29. Ireland H., Bayston T., Thompson E., et al. Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutation. Thromb Haemost 1995,73:731-2.
30. Malm J., Laurell M., Dahlbäck B. Changes in the plasma levels of vitamin-K dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988;68: 437-48.
31. Takahashi H., Tatewaki W., Wada K., Shibata A. Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy. Clin Chim Acta 1989;182:195-208.
32. Olivieri O., Friso S., Manzato F., et al. Resistance to activated protein C in healthy women taking oral contraceptives. Brit J Haematol 1995;91:465-70.
33. Cumming AM, Tait RC, Fildes S., Yoong A., Keeney S., Hay Crm. Development of resistance to activated protein C during pregnancy. Br J,Haematot 1995;90:725-7.
34. Simioni P. Prandoni P., Zanon E., et al. Deep vein thrombosis and lupus anticoagulant. A case control study. Thromb Haemost 1 996 ; 76:187-9.
35. Ames Prj, Tommasino C., lannaccone L., Brillante M., Cimino R., Brancaccio V. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies. A crucial role for acquired free protein S deficiency. Thromb Haemost 1996;76: 190-4.
36. Amer L., Kisiel W., Searles RP, Williams RC Jr.Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipinantibodies and thrombosis. Thromb Res 1990,57:247-58.
37. Bokarewa MI, Bremme K., Falk G., Sten-Linder M., Egberg N., Blombäck M. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene. Thromb Res 1995;78:193-200.
38. Ehrenforth S., Radtke KP, Scharrer I. Acquired activated protein C-resistance in patients with lupus anticoagulant. Thromb Haemost 1995;74:797-8.
39. Simioni P., Girolami A. Homozygous factor V-deficient patients show resistance to activated protein C whereas heterozygotes do not. Blood Coag Fibrinol 1994;5:825-7.
40. Colucci M., Ciavarella N., Giliberti MG, Semeraro N. Resistance to activated protein C (APC): Influence of factor V levels. Thromb Haemost 1994;72:987-8.
41. Henkens Cma, Bom Vjj, van der Mer J. Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity. Thromb Haemost 1995;74:1198-9.
42. Simioni P., Scudeller A., Radossi P., Gavasso S., Girolami B., Tormene D., Girolami A. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated families. Thromb Haemost 1996;75:422-6.
43. Lunghi B. Iacoviello L., Gemmati D., et al. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 1996;75:45-8.
44. Keeling DM Factor V:Q506 and negative APC-resistance test. Thromb Haemost 1995;74:1380-1.